Sentences with phrase «vaccine regimen in»

Collaborators are planning clinical testing of this HIV vaccine regimen in healthy adults at research sites in the U.S., East Africa, South Africa, and Thailand.

The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) initiated a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime - boost Ebola vaccine regimen in both healthy and HIV - infected volunteers.

Research Trials The HVTN also plans to test other HIV vaccine regimens in Southern Africa in a parallel research track using multiple vaccine candidates.

Not exact matches

«We seek to make TB vaccine regimens for infants and adolescents available and licensed in the next seven to nine years,» according to Yasir Skeiky, chief scientific officer of Aeras.

A team led by Ron Dagan, a pediatric infectious disease specialist at Soroka University Medical Center in Beer - Sheva, Israel, wanted to know if a new pneumococcal vaccine based on tetanus toxoid would change infants» immune responses to the standard regimen of vaccines, including those for diphtheria, tetanus, pertussis (DTP), and Haemophilus influenzae type B, which protects against meningitis.

In its first test in humans, reported online October 4 in the New England Journal of Medicine, one vaccine based on DNA from the virus elicited an immune response, with 100 percent of participants developing antibodies after a three - dose regimeIn its first test in humans, reported online October 4 in the New England Journal of Medicine, one vaccine based on DNA from the virus elicited an immune response, with 100 percent of participants developing antibodies after a three - dose regimein humans, reported online October 4 in the New England Journal of Medicine, one vaccine based on DNA from the virus elicited an immune response, with 100 percent of participants developing antibodies after a three - dose regimein the New England Journal of Medicine, one vaccine based on DNA from the virus elicited an immune response, with 100 percent of participants developing antibodies after a three - dose regimen.

Recently, monkey studies testing vaccine regimens different from those in RV144 have supported the notion that enhancing protective antibody activity may increase vaccine efficacy.

«Cholera vaccine study in Haiti suggests problems with current booster regimen.»

«Flu evolves quickly and in complex ways,» so this will help the World Health Organization (WHO) track and aim at the right strains with annual vaccines, says co-author Derek Smith, a Cambridge epidemiologist and member of the WHO committee tasked with planning WHO's annual flu shot regimen.

After initial approval of a new vaccine, research often continues and involves the testing in different populations and of different dosing regimens.

A new study led by scientists at Beth Israel Deaconess Medical Center (BIDMC) shows that an HIV - 1 vaccine regimen, involving a viral vector boosted with a purified envelope protein, provided complete protection in half of the vaccinated non-human primates (NHPs) against a series of six repeated challenges with simian immunodeficiency virus (SIV), a virus similar to HIV that infects NHPs.

An HIV - 1 version of the promising vaccine regimen is now being evaluated in an ongoing Phase 1 / 2a international clinical study.

Based on these pre-clinical data, the HIV - 1 version of this vaccine regimen is now being evaluated in an ongoing Phase 1 / 2a international clinical study sponsored by Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

«Novel HIV vaccine regimen provides robust protection in non-human primates.»

Though these particular vaccine regimens are not intended for the clinic, the results suggest that effective vaccines for MERS could be developed from the Spike protein, says study coauthor Barney Graham, a vaccinologist at the National Institute of Allergy and Infectious Diseases in Bethesda, Md..

If the WHO grants an emergency use listing, this will accelerate the availability of Janssen's investigational vaccine regimen to the international community in the event another Ebola crisis occurs.»

In the HVTN 100 study, the design and schedule of the RV144 vaccine regimen have been altered to try to increase the magnitude and duration of vaccine - elicited immune responses.

This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program - led RV144 clinical trial in Thailand — the first study to demonstrate that a vaccine can protect people from HIV infection.

In September, the team added to the vaccine regimen a drug called Keytruda that supports the immune system's attack on tumors.

Results from an initial study to ensure that the RV144 vaccine regimen is safe and well - tolerated in South African volunteers were reported at the 2014 HIV Research for Prevention (R4P) conference.

Improving the Vaccine Regimen Researchers have discovered important clues about the immune responses that may have played a role in protecting some volunteers in RV144.

Follow - up clinical studies using modified vaccine regimens and extra boosts are set to begin in Southern Africa in 2015.

The HIV Vaccine Trial Network (HVTN) plans to conduct clinical trials in heterosexual adults that will evaluate a prime - boost vaccine regimen similar to that used in RV144 adjusted to target the most common subtype of HIV in the region (subtVaccine Trial Network (HVTN) plans to conduct clinical trials in heterosexual adults that will evaluate a prime - boost vaccine regimen similar to that used in RV144 adjusted to target the most common subtype of HIV in the region (subtvaccine regimen similar to that used in RV144 adjusted to target the most common subtype of HIV in the region (subtype C).

• RV217 (ECHO): HIV - 1 Prevalence, Incidence, Cohort Retention, and Host Genetics and Viral Diversity in High Risk Cohorts in East Africa • Infectious Disease Surveillance (HIV, TB and Malaria) and Cohort Development Among Urban and Rural Communities • Karolinska Institute vaccine study in Tanzania testing a prime - boost HIV vaccine regimen using unadjuvanted DNA vaccines followed by a Modified Vaccinia Ankara (MVA), which was developed by MHRP and NIAID.

2017 — Began a new multi-site Phase 2 Ebola vaccine study at MHRP sites in Africa evaluating a prime - boost regimen in both healthy and HIV - infected volunteers (Ad26.ZEBOV from J&J; MVA - BN - Filo from Bavarian Nordic)

At the first plenary session of AIDS Vaccine 2011, which opened this morning in Bangkok, Thailand, researchers presented the results of a two - year - long effort to try to identify an immunological explanation for the modest 31 % efficacy afforded by the prime - boost vaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infVaccine 2011, which opened this morning in Bangkok, Thailand, researchers presented the results of a two - year - long effort to try to identify an immunological explanation for the modest 31 % efficacy afforded by the prime - boost vaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infvaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infection.

The new Ad26 / MVA and Ad35 / Ad26 vector - based vaccine regimens resulted in over 80 % reduction in the per - exposure probability of acquisition of infection against repetitive challenges of SIV, a virus similar to HIV that infects monkeys.

Vaccines were delivered by the intramuscular route in a ChAd63 - MVA heterologous prime - boost regimen using an 8 - week interval.

At the International AIDS Society conference in Paris, scientists announced that in an early - stage clinical trial, a new HIV vaccine regimen generated antibody responses in 100 percent of volunteers in most arms of the study.

In addition, importers in consultation with their veterinarians can elect to include Bordetella or other vaccines in their dog's vaccination regimen before or after imporIn addition, importers in consultation with their veterinarians can elect to include Bordetella or other vaccines in their dog's vaccination regimen before or after imporin consultation with their veterinarians can elect to include Bordetella or other vaccines in their dog's vaccination regimen before or after imporin their dog's vaccination regimen before or after import.

It would not be included in most dogs» annual core vaccine regimen; but, for high - risk animals it may be warranted.